Lunit and 10x Genomics to link AI pathology with spatial molecular data
On 10 September, Lunit announced a collaboration with 10x Genomics to integrate AI-enabled pathology analysis with spatial molecular data for oncology clinical research.
Who is affected and how
- pharmaceuticals
- Integrated imaging and molecular analysis can speed up biomarker research in oncology studies.
- medtech company
- Pathology AI companies gain a partnership route toward multiomics platforms.
Sources
- Lunit Announces Collaboration with 10x Genomics to Integrate AI-Enabled Pathology Analysis with Spatial Molecular Data for Oncology Clinical Researchyahoo finance · Sep 10, 2026
- Lunit, 10x Genomics integrate AI pathology, spatial data for cancer biomarker researchkorea biomedical review · Sep 11, 2026
- Korea's Lunit announces collaboration with 10x Genomics for AI-enabled pathology analysis of cancerbiospectrum asia · Sep 11, 2026
- Lunit, 10x Genomics join AI pathology and spatial data | Voice of Healthcarevohnetwork.com · Sep 11, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.